Virogin Biotech Announces Abstract Publication at the American Society of Clinical Oncology Annual Meeting
VANCOUVER, BC – Virogin Biotech today announced the acceptance of an abstract detailing initial results from its first in human trial of VG161 – the company’s lead product candidate. The… Read More



